Objective
The project aim is the further development of safe, improved poxvirus vectors for the expression of foreign antigens, for vaccination of animals and Man. The vectors have the advantage that they will be safer than earlier vaccine vectors, in that they can be used as nonreplicating poxviral vectors (NRPVs). Objectives of the project are:
(i) the development of cell lines permissive for the replication of new, non-replicating defective vaccinia vectors.
This will be achieved by transient and then permanent expression of vaccinia virus genes, which are essential to virus replication, in cell lines. These cell lines will then be used to allow isolation of viruses in which the complemented virus function is deleted;
(ii) the development of new high level promoters to optimise expression of foreign genes by non-replicating poxvirus vectors and to reduce the risk of recombination (thus increasing vector stability).
These will include natural poxvirus promoters in heterologous backgrounds as well as strong synthetic and chimaeric promoters;
(iii) the development of fusion proteins for antigen display. Epitopes will be fused to the haemagglutinin molecule of vaccinia virus and to the 39K immunodominant protein of fowlpox virus (FPV);
(iv) the development of poxviruses targeted to specific tissues.
(v) the development of new selection methods (GUS & GFP) for the isolation of poxvirus recombinants;
(vi) the identification of non-essential regions, in a host rangedefective vaccinia virus (MVA) and orf virus, suitable for the insertion of foreign genes These developments will be applied to:
(a) the artificial nonreplicating defective vaccinia virus,
(b) MVA,
(c) naturally host range-restricted FPV and
(d) attenuated orf virus, which is nonreplicating in some mammals (eg. cats an The relative efficacy of these recombinant vectors, incorporating the new developments as appropriate, will then be compared. This will be achieved by polyvalent expression of equivalent gene/promoter cassettes in the various vectors. Genes from human papilloma virus 16 (HPV-16) and from measles virus will be expressed in all the vectors (genes from canine distemper virus will be expressed initially only in orf virus).
Relative levels of foreign antigen expression by the recombinant viruses will be analysed in permissive and non-permissive cell types in vitro. The viruses will then be used in animal immunization studies, to monitor humoral and cellular responses to the foreign antigens.
Challenge/protection studies will also be performed using animal models for HPV-16, measles and canine distemper virus.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine immunology immunisation
- natural sciences biological sciences microbiology virology
- natural sciences biological sciences biochemistry biomolecules proteins
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs vaccines
- natural sciences biological sciences zoology mammalogy
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
RG20 7NN NEWBURY
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.